Compounds > lisofylline
Page last updated: 2024-08-24

lisofylline and Alloxan Diabetes

lisofylline has been researched along with Alloxan Diabetes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chitkara, D; Italiya, KS; Mahato, RI; Mazumdar, S; Mittal, A; Sharma, S1
Chen, M; Ellett, JD; Fialkow, LB; Nadler, JL; Wu, R; Yang, Z1
Nadler, JL; Striffler, JS1
Carter, JD; Chen, M; Ellett, JD; Nadler, JL; Smith, KM; Yang, Z1

Other Studies

4 other study(ies) available for lisofylline and Alloxan Diabetes

ArticleYear
Self-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus.
    Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 15, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diabetes Mellitus, Experimental; Inflammation Mediators; Insulin Secretion; Insulinoma; Linoleic Acid; Male; Micelles; Pentoxifylline; Protective Agents; Rats; Rats, Wistar; Tissue Distribution

2019
The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.
    Pancreas, 2003, Volume: 26, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Insulin; Insulin Secretion; Interferon-gamma; Interleukin-10; Interleukin-4; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Pentoxifylline; Random Allocation; Streptozocin; Tumor Necrosis Factor-alpha

2003
Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats.
    Metabolism: clinical and experimental, 2004, Volume: 53, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diabetes Mellitus, Experimental; Eating; Glucose; Glucose Tolerance Test; In Vitro Techniques; Insulin; Male; Pancreas; Pentoxifylline; Prediabetic State; Rats; Rats, Sprague-Dawley; Weight Gain

2004
Inflammation blockade improves pancreatic islet function.
    Transplantation proceedings, 2004, Volume: 36, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokines; Diabetes Mellitus, Experimental; Humans; Insulin; Insulin Secretion; Interferon-gamma; Interleukin-1; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Pentoxifylline; Recombinant Proteins; Transplantation, Heterologous; Tumor Necrosis Factor-alpha

2004